Citations (45)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Ajda Bedene, Albert Dahan, Frits R. Rosendaal & Eveline L.A. van Dorp. (2022) Opioid epidemic: lessons learned and updated recommendations for misuse involving prescription versus non-prescription opioids. Expert Review of Clinical Pharmacology 15:9, pages 1081-1094.
Read now
Read now
Malik Mumtaz Taqi, Muhammad Faisal & Hadar Zaman. (2019) OPRM1 A118G Polymorphisms and Its Role in Opioid Addiction: Implication on Severity and Treatment Approaches. Pharmacogenomics and Personalized Medicine 12, pages 361-368.
Read now
Read now
Articles from other publishers (43)
Anna Parisi, Aleksandra E. Zgierska, Cindy A. Burzinski, Robert P. Lennon, Robert N. Jamison, Yoshio Nakamura, Bruce Barrett, Robert R. Edwards & Eric L. Garland. (2023) To be aware, or to accept, that is the question: Differential roles of awareness of automaticity and pain acceptance in opioid misuse. Drug and Alcohol Dependence 247, pages 109890.
Crossref
Crossref
Courtney Brown & Anisa Ray. (2023) Substance Use Disorders and Medication-Assisted Therapies. Nursing Clinics of North America 58:2, pages 165-181.
Crossref
Crossref
Philip J. FredaJrJr, Henry R. Kranzler & Jason H. Moore. (2022) Novel digital approaches to the assessment of problematic opioid use. BioData Mining 15:1.
Crossref
Crossref
Vasantha K. Kumar. 2022. Handbook on Opium. Handbook on Opium
111
123
.
Vasantha K. Kumar. 2022. Handbook on Opium. Handbook on Opium
205
219
.
Eike-Henner W. KlugeEike-Henner W. Kluge. 2022. The Right to Health Care: Ethical Considerations. The Right to Health Care: Ethical Considerations
193
220
.
Caroul Chawar, Alannah Hillmer, Amel Lamri, Flavio Kapczinski, Lehana Thabane, Guillaume Pare & Zainab Samaan. (2021) Implications of OPRM1 and CYP2B6 variants on treatment outcomes in methadone-maintained patients in Ontario: Exploring sex differences. PLOS ONE 16:12, pages e0261201.
Crossref
Crossref
Peter J Mallow & Kathy W Belk. (2021) Cost–utility analysis of single nucleotide polymorphism panel-based machine learning algorithm to predict risk of opioid use disorder. Journal of Comparative Effectiveness Research 10:18, pages 1349-1361.
Crossref
Crossref
Caroul Chawar, Alannah Hillmer, Stephanie Sanger, Alessia D’Elia, Balpreet Panesar, Lucy Guan, Dave Xiaofei Xie, Nandini Bansal, Aamna Abdullah, Flavio Kapczinski, Guillaume Pare, Lehana Thabane & Zainab Samaan. (2021) A systematic review of GWAS identified SNPs associated with outcomes of medications for opioid use disorder. Addiction Science & Clinical Practice 16:1.
Crossref
Crossref
Emily Brandl, Zachery Halford, Matthew D. Clark & Chris Herndon. (2021) Pharmacogenomics in Pain Management: A Review of Relevant Gene-Drug Associations and Clinical Considerations. Annals of Pharmacotherapy 55:12, pages 1486-1501.
Crossref
Crossref
Joseph D. Deak & Emma C. Johnson. (2021) Genetics of substance use disorders: a review. Psychological Medicine 51:13, pages 2189-2200.
Crossref
Crossref
Amir H. Rezvani, Corinne Wells, Andrew Hawkey, Graham Blair, Reese Koburov, Ashley Ko, Andrea Schwartz, Veronica J. Kim & Edward D. Levin. (2021) Differential behavioral functioning in the offspring of rats with high vs. low self-administration of the opioid agonist remifentanil. European Journal of Pharmacology 909, pages 174407.
Crossref
Crossref
Leen Magarbeh, Ilona Gorbovskaya, Bernard Le Foll, Reuven Jhirad & Daniel J. Müller. (2021) Reviewing pharmacogenetics to advance precision medicine for opioids. Biomedicine & Pharmacotherapy 142, pages 112060.
Crossref
Crossref
Bohua Wu, William Hand & Emil Alexov. (2021) Opioid Addiction and Opioid Receptor Dimerization: Structural Modeling of the OPRD1 and OPRM1 Heterodimer and Its Signaling Pathways. International Journal of Molecular Sciences 22:19, pages 10290.
Crossref
Crossref
Maggie L McCorkle, David F Kisor, Caroline E Freiermuth & Jon E Sprague. (2021) Systematic review of Pharmacogenomics Knowledgebase evidence for pharmacogenomic links to the dopamine reward pathway for heroin dependence. Pharmacogenomics 22:13, pages 849-857.
Crossref
Crossref
David Bright, Anna Langerveld, Susan DeVuyst-Miller, Claire Saadeh, Ashley Choker, Elisabeth Lehigh, Stephanie Wheeler, Ahed Zayzafoon & Minji Sohn. (2021) Identification of a sex-stratified genetic algorithm for opioid addiction risk. The Pharmacogenomics Journal 21:3, pages 326-335.
Crossref
Crossref
Sara Sadat Aghabozorg Afjeh, Behzad Boshehri, Safar Hamednia, Asmaolhosna Amini, Parisa Mashayekhi & Mir Davood Omrani. (2021) Investigating the CYP2B6 rs3745274 and rs3211371 polymorphisms in Methadone-Responder and Non-Responder Addicts in Iran. Iranian Biomedical Journal 25:3, pages 220-225.
Crossref
Crossref
Sandra Lopez-Leon, Yeimy González-Giraldo, Talia Wegman-Ostrosky & Diego A. Forero. (2021) Molecular genetics of substance use disorders: An umbrella review. Neuroscience & Biobehavioral Reviews 124, pages 358-369.
Crossref
Crossref
Yaa Abu & Sabita Roy. (2021) Prenatal opioid exposure and vulnerability to future substance use disorders in offspring. Experimental Neurology 339, pages 113621.
Crossref
Crossref
Lynn M. Oswald, Kelly E. Dunn, David A. Seminowicz & Carla L. Storr. (2021) Early Life Stress and Risks for Opioid Misuse: Review of Data Supporting Neurobiological Underpinnings. Journal of Personalized Medicine 11:4, pages 315.
Crossref
Crossref
Christopher W. Meaden, Alexander Mozeika, Rijul Asri & Cynthia D. Santos. (2020) A review of the existing literature on buprenorphine pharmacogenomics. The Pharmacogenomics Journal 21:2, pages 128-139.
Crossref
Crossref
Philip J. Freda, Jason H. Moore & Henry R. Kranzler. (2021) The phenomics and genetics of addictive and affective comorbidity in opioid use disorder. Drug and Alcohol Dependence 221, pages 108602.
Crossref
Crossref
Sumanth Kuppalli, Raghav Seth, Vwaire Orhurhu, Ivan Urits, Alan D. Kaye, Corey Hunter, Amitabh Gulati, Peju Adekoya, Adam M. Kaye & Mark R. Jones. (2021) Recent Advances in the Treatment of Opioid Use Disorder. Current Pain and Headache Reports 25:4.
Crossref
Crossref
Camron D. Bryant, Aidan F. Healy, Qiu T. Ruan, Michal A. Coehlo, Elijah Lustig, Neema Yazdani, Kimberly P. Luttik, Tori Tran, Isaiah Swancy, Lindsey W. Brewin, Melanie M. Chen & Karen K. Szumlinski. (2020)
Sex‐dependent effects of an
Hnrnph1
mutation on fentanyl addiction‐relevant behaviors but not antinociception in mice
. Genes, Brain and Behavior 20:3.
Crossref
Crossref
Chad A. Bousman, Susanne A. Bengesser, Katherine J. Aitchison, Azmeraw T. Amare, Harald Aschauer, Bernhard T. Baune, Bahareh Behroozi Asl, Jeffrey R. Bishop, Margit Burmeister, Boris Chaumette, Li-Shiun Chen, Zachary A. Cordner, Jürgen Deckert, Franziska Degenhardt, Lynn E. DeLisi, Lasse Folkersen, James L. Kennedy, Teri E. Klein, Joseph L. McClay, Francis J. McMahon, Richard Musil, Nancy L. Saccone, Katrin Sangkuhl, Robert M. Stowe, Ene-Choo Tan, Arun K. Tiwari, Clement C. Zai, Gwyneth Zai, Jianping Zhang, Andrea Gaedigk & Daniel J Müller. (2020) Review and Consensus on Pharmacogenomic Testing in Psychiatry. Pharmacopsychiatry 54:01, pages 5-17.
Crossref
Crossref
Santi M. Spampinato. 2021. Opioid Receptors. Opioid Receptors
3
13
.
Alexey KozlenkovMarit W. Vermunt, Pasha ApontesJunhao LiKe HaoChet C. Sherwood, Patrick R. HofJohn J. ElyMichael Wegner, Eran A. Mukamel, Menno P. CreyghtonEugene V. Koonin & Stella Dracheva. (2020) Evolution of regulatory signatures in primate cortical neurons at cell-type resolution. Proceedings of the National Academy of Sciences 117:45, pages 28422-28432.
Crossref
Crossref
Reda M. Chalhoub & Peter W. Kalivas. (2020) Non-Opioid Treatments for Opioid Use Disorder: Rationales and Data to Date. Drugs 80:15, pages 1509-1524.
Crossref
Crossref
Frank R. Wendt & Bruce Budowle. (2019) Pharmacogenetics and the postmortem molecular autopsy. WIREs Forensic Science 2:3.
Crossref
Crossref
Daniel W. Odell, Ken B. Johnson, Alan R. Light, Ami R. Stuart & Kathleen C. Light. (2020) Gene Variants in Hepatic Metabolism, Gamma-Aminobutyric Acid-ergic Reward, and Prostaglandin Pathways in Opioid-Consuming and Opioid-Naïve Patients Presenting for Lower Extremity Total Joint Replacement. Anesthesia & Analgesia 130:3, pages e67-e70.
Crossref
Crossref
Jessica Pelkowski. (2020) Pharmacogenetic Considerations in Opioid Therapy Prescribing. The Journal for Nurse Practitioners 16:3, pages 201-204.
Crossref
Crossref
Mark C. Bicket, Ju Nyeong Park, Arissa Torrie, Sean T. Allen, Brian W. Weir & Susan G. Sherman. (2020) Factors associated with chronic pain and non-medical opioid use among people who inject drugs. Addictive Behaviors 102, pages 106172.
Crossref
Crossref
Wendy Umberger & Lynn Gaddis. (2020) The Science of Addiction Through the Lens of Opioid Treatment for Chronic Noncancer Pain. Pain Management Nursing 21:1, pages 57-64.
Crossref
Crossref
Hsin-Wen Chang, Wen-Chao Ho, Chieh-Liang Huang & Ruey-Yun Wang. (2020) Precision therapeutic opioid dosing implications from genetic biomarkers and craving score. Medicine 99:22, pages e20429.
Crossref
Crossref
Jermaine D. Jones, Mudassir Mumtaz, Jeanne M. Manubay, Shanthi Mogali, Elliana Sherwin, Suky Martinez & Sandra D. Comer. (2019) Assessing the contribution of opioid- and dopamine-related genetic polymorphisms to the abuse liability of oxycodone. Pharmacology Biochemistry and Behavior 186, pages 172778.
Crossref
Crossref
Louisa Degenhardt, Jason Grebely, Jack Stone, Matthew Hickman, Peter Vickerman, Brandon D L Marshall, Julie Bruneau, Frederick L Altice, Graeme Henderson, Afarin Rahimi-Movaghar & Sarah Larney. (2019) Global patterns of opioid use and dependence: harms to populations, interventions, and future action. The Lancet 394:10208, pages 1560-1579.
Crossref
Crossref
Marissa A. Ehringer. (2019) Identifying epigenetic targets underlying the effects of prenatal exposure to opioids. Genes, Brain and Behavior 18:6.
Crossref
Crossref
Hendrée E. Jones & Walter K. Kraft. (2019) Analgesia, Opioids, and Other Drug Use During Pregnancy and Neonatal Abstinence Syndrome. Clinics in Perinatology 46:2, pages 349-366.
Crossref
Crossref
Janet Robishaw, Jennifer Caceres & Charles H. Hennekens. (2019) Genomics and Precision Medicine to Combat Opioid Use Disorder. The American Journal of Medicine 132:4, pages 395-396.
Crossref
Crossref
Hestia Moningka, Sarah Lichenstein & Sarah W. Yip. (2019) Current Understanding of the Neurobiology of Opioid Use Disorder: an Overview. Current Behavioral Neuroscience Reports 6:1, pages 1-11.
Crossref
Crossref
Tando Maduna, Emilie Audouard, Doulaye Dembélé, Nejma Mouzaoui, David Reiss, Dominique Massotte & Claire Gaveriaux-Ruff. (2019) Microglia Express Mu Opioid Receptor: Insights From Transcriptomics and Fluorescent Reporter Mice. Frontiers in Psychiatry 9.
Crossref
Crossref
Ji-ming Wang, Fu Xu, Gang Peng & Sheng Lu. (2018) Efficacy and Safety of Sufentanil-Propofol Versus Remifentanil-Propofol as Anesthesia in Patients Undergoing Craniotomy: A Meta-Analysis. World Neurosurgery 119, pages e598-e606.
Crossref
Crossref
Kevin P. Jensen, Elise E. DeVito, Sarah Yip, Kathleen M. Carroll & Mehmet Sofuoglu. (2018) The Cholinergic System as a Treatment Target for Opioid Use Disorder. CNS Drugs 32:11, pages 981-996.
Crossref
Crossref